Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
Clinical trial NCT03701217 · UNKNOWN
Trial details
- NCT number
- NCT03701217
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2019-09-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.